Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis. Starrenburg ME, Bel Imam M, Lopez JF, Buergi L, et al. J Allergy Clin Immunol 2024;154:1333-1338.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Starrenburg ME, Bel Imam M, Lopez JF, Buergi L, et al. Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis. J Allergy Clin Immunol 2024;154:1333-1338.
PMID: 39038586